Jie Huang | Biological Sciences | Best Researcher Award

Dr. Jie Huang | Biological Sciences | Best Researcher Award

University of Oxford | United Kingdom

Dr. Jie Huang (黄杰), is a distinguished plant biologist currently serving as a postdoctoral researcher at the Department of Biology, University of Oxford. His research focuses on molecular plant–pathogen interactions, alternative splicing, and effector biology. Dr. Huang has made substantial contributions to our understanding of how pathogens manipulate plant immune responses and has published widely in high-impact journals.

Professional profile👤

Google Scholar

Strengths for the Awards✨

1. Strong Academic Background & Training

  • PhD from Nanjing Agricultural University under a leading expert, Prof. Suomeng Dong.

  • Postdoctoral experience at the prestigious University of Oxford, a global hub for biological sciences.

2. Consistent and High-Impact Research Output

  • Multiple first-author and corresponding-author publications in top-tier journals such as Nature Communications, Advanced Science, The Plant Cell, Molecular Plant, and New Phytologist.

  • His research appears in elite plant biology and molecular journals, indicating significant peer recognition and impact.

3. Innovation in Research

  • Pioneered discoveries related to alternative splicing in plant immunity, plant-pathogen interactions, and protein-peptide interactions, a critical frontier in molecular plant pathology.

  • Integration of computational tools (AlphaFold-Multimer) in cross-kingdom interaction studies, reflecting interdisciplinary sophistication.

4. Competitive Funding Record

  • Secured prestigious funding from national (NSFC), provincial, and postdoctoral foundations in China as Principal Investigator, demonstrating independent scientific leadership.

5. International Collaboration & Mobility

  • Experience at institutions in China, the UK, and the USA, showcasing global integration and collaborative capacity.

  • Short-term training and collaborative publications with international partners, enhancing his scientific network and adaptability.

🎓 Education

 Dr. Huang began his academic journey with a Bachelor’s degree in Plant Science from Anhui Agricultural University (2009–2013). He then pursued his Ph.D. in Plant Pathology at Nanjing Agricultural University (2013–2018), where he was mentored by the esteemed Prof. Suomeng Dong. His doctoral research laid a strong foundation for his expertise in host–pathogen molecular dynamics.

🧪 Experience

 Following his Ph.D., Dr. Huang worked as a postdoctoral researcher at Nanjing Agricultural University (2018–2021), continuing under Prof. Dong’s supervision. In 2019, he broadened his global research exposure as a visiting scholar at Colorado State University with Prof. Anireddy Reddy. Since January 2022, he has been advancing his research at the University of Oxford under Prof. Renier A. L. van der Hoorn, contributing to frontier studies in plant proteomics and immunity.

🔬 Research Interests On Biological Sciences

🌿 Dr. Huang’s research delves into:

  • Alternative splicing in plant immunity

  • Effector biology in oomycete pathogens

  • Protease-targeting mechanisms at the plant–pathogen interface

  • Use of AlphaFold and other computational tools to predict protein interactions
    His work bridges molecular biology, bioinformatics, and biotechnology for improving crop resistance strategies.

🏆 Awards and Funding

 As a Principal Investigator, Dr. Huang has secured several prestigious research grants, including:

  • National Natural Science Foundation of China (No. 31901862)

  • Natural Science Foundation of Jiangsu Province (SBK2019040604)

  • Fundamental Research Funds for Central Universities (KYQN202009)

  • China Postdoctoral Science Foundation (2018M640494)

  • Special Postdoctoral Science Fund (2020T130306)

These awards reflect his scientific rigor and innovative research in plant molecular biology.

📚 Publications

1. A Phytophthora effector manipulates host histone acetylation and reprograms defense gene expression to promote infection
Authors: L Kong, X Qiu, J Kang, Y Wang, H Chen, J Huang, M Qiu, Y Zhao, G Kong, …
Year: 2017
Cited by: 144

2. An oomycete plant pathogen reprograms host pre-mRNA splicing to subvert immunity
Authors: J Huang, L Gu, Y Zhang, T Yan, G Kong, L Kong, B Guo, M Qiu, Y Wang, …
Year: 2017
Cited by: 120

3. Phytophthora effectors modulate genome-wide alternative splicing of host mRNAs to reprogram plant immunity
Authors: J Huang, X Lu, H Wu, Y Xie, Q Peng, L Gu, J Wu, Y Wang, ASN Reddy, …
Year: 2020
Cited by: 84

4. The Activation of Phytophthora Effector Avr3b by Plant Cyclophilin is Required for the Nudix Hydrolase Activity of Avr3b
Authors: G Kong, Y Zhao, M Jing, J Huang, J Yang, Y Xia, L Kong, W Ye, Q Xiong, …
Year: 2015
Cited by: 84

5. The Phytophthora sojae RXLR effector Avh238 destabilizes soybean Type2 GmACSs to suppress ethylene biosynthesis and promote infection
Authors: B Yang, Y Wang, B Guo, M Jing, H Zhou, Y Li, H Wang, J Huang, Y Wang, …
Year: 2019
Cited by: 71

6. AlphaFold-Multimer predicts cross-kingdom interactions at the plant-pathogen interface
Authors: F Homma, J Huang, RAL van der Hoorn
Year: 2023
Cited by: 69

7. Pathogen manipulation of chloroplast function triggers a light-dependent immune recognition
Authors: C Gao, H Xu, J Huang, B Sun, F Zhang, Z Savage, C Duggan, T Yan, …
Year: 2020
Cited by: 65

8. Cleavage of a pathogen apoplastic protein by plant subtilases activates host immunity
Authors: S Wang, R Xing, Y Wang, H Shu, S Fu, J Huang, JK Paulus, M Schuster, …
Year: 2021
Cited by: 40

9. Natural allelic variations provide insights into host adaptation of Phytophthora avirulence effector PsAvr3c
Authors: J Huang, L Chen, X Lu, Q Peng, Y Zhang, J Yang, BY Zhang, B Yang, …
Year: 2019
Cited by: 32

10. Phytophthora sojae apoplastic effector AEP1 mediates sugar uptake by mutarotation of extracellular aldose and is recognized as a MAMP
Authors: Y Xu, Y Zhang, J Zhu, Y Sun, B Guo, F Liu, J Huang, H Wang, S Dong, …
Year: 2021
Cited by: 31

📝 Conclusion

🌟 Dr. Jie Huang is a rising star in plant molecular biology, combining classical genetics, proteomics, and cutting-edge computational tools to unravel the complexities of plant immunity and pathogen virulence. His international collaborations, funding success, and impactful publications position him as a strong nominee for any prestigious research award recognizing scientific excellence in plant sciences.

Zhanbin Wang | Biological Sciences | Lifetime achievement Award

Prof. Dr. Zhanbin Wang | Biological Sciences | Lifetime achievement Award

Northeast Forestry University | China

Dr. Wang Zhanbin is an Associate Professor in the College of Forestry at Northeast Forestry University, China. With over 25 years of experience in forest pathology, he is also the Director of the Forest Pathology Credit Committee of the Chinese Forestry Society. He is proficient in English and actively supervises master’s students while teaching courses like Integrated Management of Forest Pests. His extensive work focuses on plant disease resistance, forest pest management, and ecological sustainability.

Professional profile👤

Scopus

Strengths for the Awards✨

  1. Extensive Career Duration and Experience:
    With a professional journey spanning over three decades (from 1994 to present), Dr. Wang has consistently worked in the field of forest protection, particularly focusing on forest pathology and molecular biology of forest diseases.

  2. Significant Scientific Contributions:
    He has received multiple prestigious awards at provincial and national levels, including:

    • 1st Prize from Liaoning Provincial Forestry Department (2015),

    • Multiple 2nd and 3rd Prizes from the Heilongjiang Province Science and Technology Progress Awards,

    • Liangxi Forestry Science and Technology Award (twice).
      These awards reflect sustained and impactful contributions to applied forestry research, particularly in disease resistance in poplar and sustainable pest control.

  3. Academic Productivity:
    His work has been published in SCI-indexed journals and national agricultural bulletins. His recent research includes studies on microbial interactions, transcriptomics, and triterpenoid biosynthesis — showing both depth and evolution in research focus.

  4. Leadership and Social Service:
    Dr. Wang holds a leadership position as Director of the Forest Pathology Credit Committee of the Chinese Forestry Society, indicating strong recognition by the national academic community.

  5. Educational Contributions:
    He has trained Master’s students, taught specialized courses like Integrated Management of Forest Pests, and contributed to several important textbooks and national teaching materials — reinforcing his academic leadership.

  6. Interdisciplinary Application:
    His work bridges plant pathology, molecular biology, genetics, and environmental management, contributing to real-world forest sustainability and plant health.

🎓 Education

Dr. Wang holds a PhD in Forest Protection (2007) from Northeast Forestry University. He earned his Master’s in Genetic Engineering (2003) from Harbin Normal University and a Bachelor’s degree in Forest Protection (1994) from Northeast Forestry University. He furthered his research as a postdoctoral fellow (2009–2012) at Jilin Yanbian Forestry Group.

💼 Experience

  • 2005–Present: Associate Professor, College of Forestry, Northeast Forestry University

  • 2003–2005: Teaching Assistant, Northeast Forestry University

  • 1997–2003: Research Assistant, Institute of Microbiology, Heilongjiang Academy of Sciences
    Dr. Wang has consistently contributed to forest pathology, particularly in fungal disease resistance and pest management.

🔬 Research Interests On Biological Sciences

His key research areas include:

  • Forest Pathology

  • Molecular Biology of Forest Diseases

  • Transgenic Disease-Resistant Poplars

  • Integrated Pest and Disease Management in Coniferous-Broadleaf Forests
    He integrates lab-based molecular work with field-based ecological applications.

🏆 Awards

Dr. Wang has received numerous honors, including:

  • 2005: Third Prize, Chinese Forestry Society, for transgenic fungal resistance in poplar

  • 2010 & 2011: Heilongjiang Science & Technology Progress Awards

  • 2015: First Prize, Liaoning Provincial Forestry Department, for breeding stress-resistant poplar

  • 2017 & 2022: Liangxi Forestry Science & Technology Awards for disease control in artificial forests and ecological regulation techniques
    These awards underscore his innovation in forest biotechnology and sustainability.

📚 Publications

Below are Dr. Wang’s key peer-reviewed publications from recent years, including hyperlinks and citation contexts:

  1. 2023 – Effect of powdery mildew on interleaf microbial communities and leaf antioxidant enzyme systems, Journal of Forestry Research – cited by 2

  2. 2022 – Transcriptional Responses for Biosynthesis of Triterpenoids in Exogenous Inducers Treated Inonotus hispidus Using RNA-Seq, Molecules – cited by 3

  3. 2022Effects of Compound Elicitors on the Biosynthesis of Triterpenoids and Activity of Defense Enzymes from Inonotus hispidus, Molecules – cited by 1

  4. 2022The Powdery Mildew on Polygonum persicaria L.: Microscopic Observation and Phylogenetic Relationship Analysis, Chinese Agricultural Science Bulletin, 38(9):130–136

  5. 2022Isolation of Endophytic Fungi from Medicinal Plants and Screening and Identification of Antagonism, Chinese Agricultural Science Bulletin, 38(1):75–81

📖 He has also contributed to several academic books and national-level teaching materials on forest pathology and quarantine.

✅ Conclusion

Dr. Wang Zhanbin is a dedicated forest pathology expert whose innovations in disease-resistant poplars and integrated pest management have had a lasting impact on forestry research in China. His scholarly output, teaching excellence, and technological contributions make him a distinguished nominee for any scientific recognition in environmental and biological sciences.

Hamid Zaferani Arani | Biology | Best Researcher Award

Dr. Hamid Zaferani Arani | Biology | Best Researcher Award

Department of Surgery, Shiraz University of Medical Sciences | Iran

Dr. Hamid Zaferani Arani is an accomplished Iranian Medical Doctor (M.D.) and President of the knowledge-based company Ideh Pardazan Teb Gostar. A prolific researcher in oncology, neuroscience, and regenerative medicine, he has authored numerous publications, books, and patents. Recognized as a top national medical student (2021), his work spans clinical studies, biomedical innovation, and medical education.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  1. Extensive Research Output

    • Dr. Arani has a prolific publication record, with multiple peer-reviewed articles in reputable journals, including Plos OneOxidative Medicine and Cellular Longevity, and Journal of Cancer Research and Therapeutics.

    • His research spans cancer biology, neuroscience, regenerative medicine, and clinical medicine, demonstrating multidisciplinary expertise.

  2. Academic and Professional Leadership

    • President of a knowledge-based medical equipment company, indicating applied research and innovation in medical technology.

    • Active involvement in research centers (Cognitive and Neuroscience Research Center, Cancer Research Center) and professional associations (Iran’s National Elites Foundation).

  3. Conference Participation and Recognition

    • Invited speaker and board member at multiple international and national conferences (e.g., LIMSC in the Netherlands, International Breast Cancer Congress).

    • Recipient of numerous awards, including “Distinctive Researcher” (2016-2021) and “Top Student in Medicine in Iran” (2021).

  4. Innovation and Patents

    • Holds multiple patents, including medical devices and therapeutic formulations (e.g., oral medicine for neonatal jaundice, hearing aid technology).

    • Demonstrates translational research impact, bridging laboratory findings with clinical and industrial applications.

Education 🎓

  • M.D. (2014–2021): Faculty of Medicine, Islamic Azad University, Tehran Medical Sciences.

  • Research Training: Cognitive Neuroscience (CNRC), Cancer Research Center (Shahid Beheshti University), and international workshops in Leiden, Netherlands (2017) on medical statistics, publishing, and innovation.

Experience 💼

  • PresidentIdeh Pardazan Teb Gostar (Dayan ATA MEDICA), leading R&D in medical equipment.

  • Researcher: Collaborated with Shahid Beheshti University on breast cancer studies (2016–2021).

  • Educator: Taught medical statistics, scientific writing, and research methodology at Islamic Azad University.

Research Interests On Biology 🔬

  • Cancer Biology: Biomarkers, breast cancer, and therapeutic agents (e.g., HypericinNaringenin).

  • Neuroscience: Cerebral ischemia, neuroprotection, and drug effects (e.g., FK506Atorvastatin).

  • Regenerative Medicine: Scaffold engineering, wound healing, and amniotic membrane applications.

Awards & Honors 🏆

  • Top National Medical Student (2021)

  • Distinctive Researcher (2016–2020, Islamic Azad University)

  • Best Startup Idea (2019, ITEM Weekend)

  • Top Speaker at LIMSC (Leiden, 2017)

Publications 📜

  • Title: EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
    Authors: M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, …
    Year: 2022
    Citations: 115

  • Title: Hydrogels based on cellulose and its derivatives: applications, synthesis, and characteristics
    Authors: S Ghorbani, H Eyni, SR Bazaz, H Nazari, LS Asl, H Zaferani, V Kiani, …
    Year: 2018
    Citations: 60

  • Title: Verapamil Inhibits Mitochondria‐Induced Reactive Oxygen Species and Dependent Apoptosis Pathways in Cerebral Transient Global Ischemia/Reperfusion
    Authors: E Jangholi, ZN Sharifi, M Hoseinian, MR Zarrindast, HR Rahimi, A Mowla, …
    Year: 2020
    Citations: 44

  • Title: Understanding the clinical and demographic characteristics of second coronavirus spike in 192 patients in Tehran, Iran: A retrospective study
    Authors: H Zaferani Arani, G Dehghan Manshadi, HA Atashi, A Rezaei Nejad, …
    Year: 2021
    Citations: 30

  • Title: Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
    Authors: M Hashemi, HZ Arani, S Orouei, E Rostamnejad, A Ghorbani, …
    Year: 2022
    Citations: 21

  • Title: Cyanidin 3-glycoside induced apoptosis in MCF-7 breast cancer cell line
    Authors: SA Mirmalek, S Faraji, S Ranjbaran, H Aryan, HZ Arani, E Jangholi, …
    Year: 2020
    Citations: 15

  • Title: A comparative study on effective factors in patient safety culture from the nursing staff points of view
    Authors: K Alimohammadzadeh, S Esmaili Joladi, M Olya, A Ghaiyoomi, …
    Year: 2017
    Citations: 15

  • Title: Comparing the effects of oleoresin of Pistacia atlantica tree and diclofenac gel on the knee osteoarthritis improvement
    Authors: M Peivastegan, M Rajabi, HZ Arani, M Olya, HA Atashi, S Abolghasemi
    Year: 2020
    Citations: 12

  • Title: Knowledge, attitudes, and practices toward breast cancer: among midwives in a breast cancer educational seminar in Tehran
    Authors: HA Atashi, ME Vaghar, M Olya, P Mirzamohammadi, HZ Arani, …
    Year: 2020
    Citations: 9

  • Title: Effect of topical Areca palm L. hydroalcoholic extract on burn wound healing in rats
    Authors: Z Abbasy, AA Tameh, R Mozaffari-Kermani, HZ Arani, SA Talaei
    Year: 2021
    Citations: 7

Conclusion 🌟

Dr. Zaferani Arani exemplifies translational research, bridging clinical medicine with innovation. His leadership in knowledge-based enterprises, coupled with 50+ publications and 10+ patents, underscores his commitment to advancing healthcare. A dynamic educator and researcher, he continues to explore frontiers in cancer therapy, neuroprotection, and medical technology.